Acute Gouty Arthritis
Conditions
Interventions
Treatment Group:Delivery of diclofenac diethylamine emulgel via nano plum-blossom needle
Control Group 1:Soothing nano plum-blossom needle plus external use of diclofenac diethylamine emulgel
Control Group 2:acupuncture using nano plum-blossom needle
Sponsors
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Those conformed to meet the diagnostic criteria for acute gouty arthritis; 2. Aged between 18 and 65 years old; 3. Those signing the informed consent to participate in the clinical research; 4. Those never taking relevant therapeutics since the acute pain attack; 5. Those having a VAS pain score above 3 and below 8.
Exclusion criteria
Exclusion criteria: 1. Those suffering active gastrointestinal bleeding, or having suffered recurrent ulcer or bleeding; 2. Those allergic to NSAIDs; 3. Those suffering severe joint deformity and limitation of motion; 4. Those concurrently taking other drugs related to the treatment of this disease; 5. Those suffering comorbidities of primary diseases, such as severe cardiovascular, cerebrovascular, hepatic, renal and hemopoietic system diseases or systemic failures, diabetes (poor glycemic control, FBG >10umol/l), malignant tumor, mental diseases; 6. Those who are pregnant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pain intensity of acute gouty arthritis; | — |
Countries
China
Contacts
Public ContactZhang Lu
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Outcome results
None listed